Probo Medical Completes Acquisition of National Ultrasound

Summation

  • National was founded in 2003 in Duluth, GA and has grown to be one of the largest ultrasound marketing and sales organizations in the country.
  •   The depth, breadth and value proposition of Probo’s offering in ultrasound is second to none and we are excited to share that with our customers,”.
  • Over recent years, National has established themselves as a premier provider of ultrasound sales and support to veterinary practices across the country.

Probo Medical (“Probo”), a leading global provider of medical imaging equipment, parts, repair and service, announced the acquisition of National Ultrasound, Inc. (“National”). Terms of the transaction were not disclosed.

National was founded in 2003 in Duluth, GA and has grown to be one of the largest ultrasound marketing and sales organizations in the country. National has been recognized in the Inc. 5000 list of fastest growing companies for seven consecutive years. Their team brings over 250 years of combined experience working with major ultrasound OEM’s. Over recent years, National has established themselves as a premier provider of ultrasound sales and support to veterinary practices across the country.

“National has a deep history for their sales and marketing prowess, selling new and pre-owned ultrasound equipment to private practices across the country,” said Michael Asmer, CEO of Probo. “They have leveraged that position to expand into the veterinary market.  The opportunity to connect this expertise to our world-class ultrasound sales, service, and repair services is tremendously exciting.”

“National has been a business built on relationships: with our employees, customers and OEM partners.  We found the same values in Probo as we were looking for a partner that could support, and even accelerate, our growth.  The depth, breadth and value proposition of Probo’s offering in ultrasound is second to none and we are excited to share that with our customers,” said Joe Williams, CEO of National.

Probo Medical is backed by Avista Capital Partners, a leading New York-based private equity firm with more than 40 growth-oriented healthcare businesses globally.

More News

Mira Pharmaceuticals Announces DEA Rules MIRA-55, a Novel Oral Pharmaceutical Marijuana Analog, Is Not Classified as a Controlled Substance

"We are thrilled with the DEA's decision, which underscores the potential of MIRA-55 as a groundbreaking therapeutic candidate," said Erez Aminov, Chairman & CEO of MIRA Pharmaceuticals. "This ruling allows us to focus on MIRA-55's unique cognitive and anxiety benefits. With access to $90B traditional neurological and $30B cannabis markets, MIRA-55 represents a significant value proposition for our company.  We remain committed to advancing it through the development pipeline for treating these diseases from which so many currently suffer."

Abu Dhabi Issues First BioTech Inventor-Class Golden Visa to Catalyze “Made-In-Abu-Dhabi IP” to Rockefeller University Inventor Dr Kambiz Shekdar, PhD

Dr Kambiz Shekdar said: "I gratefully take this opportunity as my solemn commitment to help build up the BioTech sector in Abu Dhabi with the same home-grown can-do-and-have-done record of accomplishment demonstrated by Emirati leadership, its people, and nation, and to do so collegially with the best of the best of the world's human capital across frontier technologies who, like myself, are drawn to the UAE with the thirst to pioneer and build better like only possible in the red-hot entrepreneurial climate of the UAE."

Activation Capital Introduces ‘Frontier BioHealth’ to Catalyze Life Science Startups

"We celebrate the growing base of research and technological advances within the region's health and life sciences sector," said Chandra Briggman, President and CEO of Activation Capital.

By using this website you agree to accept Medical Device News Magazine Privacy Policy